RQ-00311651 is a selective T-type calcium channel antagonist that predominantly targets the Cav3.2 isoform, which is implicated in neuropathic and visceral pain modulation. This compound effectively inhibits T currents in HEK293 cells expressing human Cav3.1 and Cav3.2, as well as reducing calcium signaling induced by elevated potassium levels. Additionally, RQ-00311651 demonstrates antiallergic effects and has shown efficacy in preclinical models, including reduction of acute pancreatitis and cystitis in mice following administration via oral or intraperitoneal routes. This compound offers significant potential for research in pain management and related pathological conditions.
RQ-00311651 is a selective T-type calcium channel antagonist that predominantly targets the Cav3.2 isoform, which is implicated in neuropathic and visceral pain modulation. This compound effectively inhibits T currents in HEK293 cells expressing human Cav3.1 and Cav3.2, as well as reducing calcium signaling induced by elevated potassium levels. Additionally, RQ-00311651 demonstrates antiallergic effects and has shown efficacy in preclinical models, including reduction of acute pancreatitis and cystitis in mice following administration via oral or intraperitoneal routes. This compound offers significant potential for research in pain management and related pathological conditions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
